Alnylam Pharmaceuticals

Alnylam Pharmaceuticals in Fortune Rankings

Best Large Workplaces in Biotechnology and Pharmaceuticals 2026

Employees say:

"This is the hardest working group of people collectively that I've had the pleasure of working with. Because of that, the majority of us embody our core values and treat everyone with respect and kindness to get the job done.  We're unique in that we are at the forefront of our technology and making decisions on how we do our work that takes into account yield of product, functionality/flow, and safety/environmental is our specialty. The people at Alnylam are comfortable being uncomfortable and doing things that have never been done before."

  • Updated:6/3/26
  • Country/Territory:U.S.
  • Headquarters:Cambridge, Mass.
  • Industry:Pharmaceuticals
  • CEO:Yvonne L. Greenstreet
  • Website:https://www.alnylam.com/
  • Ticker:ALNY
  • Company type:Public
  • Revenues ($M):$3,714
  • Profits ($M):$314
  • Market value ($M):$43,881
  • Number of employees:2,500

Market value as of March 31, 2026.

Alnylam Pharmaceuticals stock chart

Alnylam Pharmaceuticals in Fortune Rankings